Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotics and pharmacogenomics.

Daniel B Davison1, John F Barrett

  • 1Bristol-Myers Squibb Pharmaceutical Research Institute, Lawrenceville, NJ 08534, USA. daniel.davison@ bms.com

Pharmacogenomics
|August 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibacterial and mechanism of action studies of boxazomycin A.

The Journal of antibiotics·2024
Same author

Overview of anti-infective drug development.

Current protocols in pharmacology·2011
Same author

Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa.

Journal of natural products·2009
Same author

Isolation, structure, and antibacterial activity of thiazomycin A, a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa.

Bioorganic & medicinal chemistry·2008
Same author

An overview of sequence similarity ("homology") searching.

Current protocols in bioinformatics·2008
Same author

Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347.

Journal of the American Chemical Society·2008

Antibiotic use affects bacteria and hosts, necessitating improved strategies. Pharmacogenomics can analyze antibiotic impacts on pathogens and hosts to optimize treatment and combat resistance.

Area of Science:

  • Microbiology
  • Pharmacology
  • Genomics

Background:

  • Antibiotics are crucial for treating bacterial infections but their widespread use has complex effects on bacterial ecology and host health.
  • Both beneficial and detrimental impacts necessitate careful consideration of antibiotic usage and the emergence of antibiotic resistance.

Purpose of the Study:

  • To explore the novel application of pharmacogenomics for analyzing the impact of antibiotic therapy.
  • To determine and analyze the effects of antibiotics on both bacterial pathogens and the host.
  • To improve antibiotic placement and usage strategies in clinical settings.

Main Methods:

  • The study proposes the use of pharmacogenomics as a novel method.
  • This approach involves analyzing the molecular and genetic responses of both pathogens and hosts to antibiotic treatment.

Related Experiment Videos

Main Results:

  • Pharmacogenomics offers a potential framework for understanding the multifaceted impacts of antibiotic therapy.
  • This approach can aid in assessing emerging antibiotic resistance patterns.
  • It provides insights into optimizing antibiotic efficacy and minimizing host-related adverse effects.

Conclusions:

  • Pharmacogenomics presents a novel avenue for evaluating antibiotic therapy's effects on pathogens and hosts.
  • This discipline can contribute to refining antibiotic usage guidelines and combating antimicrobial resistance.
  • Further development and application of pharmacogenomics are recommended for optimizing antibiotic stewardship.